Comment on

• Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes.

  Roumie CL, Greevy RA, Grijalva CG, Hung AM, Liu X, Murff HJ, Elasy TA, Griffin MR. Roumie CL, et al. JAMA. 2014 Jun 11;311(22):2288-96. doi: 10.1001/jama.2014.4312. JAMA. 2014. PMID: 24915260 Free PMC article.
• Insulin vs sulfonylureas for second-line diabetes treatment.

  Tasci I, Safer U. Tasci I, et al. JAMA. 2014 Oct 22-29;312(16):1693. doi: 10.1001/jama.2014.11114. JAMA. 2014. PMID: 25335154 No abstract available.